2-[2-[(2R,6S)-2-(2-methyl-3H-imidazo[1,2-a]pyridin-2-yl)-6-(3-methyl-2-pyridinyl)piperidin-1-yl]ethyl]-1,3-oxazole

C24H29N5O — CID 155373966

IUPAC2-[2-[(2R,6S)-2-(2-methyl-3H-imidazo[1,2-a]pyridin-2-yl)-6-(3-methyl-2-pyridinyl)piperidin-1-yl]ethyl]-1,3-oxazole
SMILESCc1cccnc1[C@@H]1CCC[C@H](C2(C)CN3C=CC=CC3=N2)N1CCc1ncco1
InChIInChI=1S/C24H29N5O/c1-18-7-6-12-26-23(18)19-8-5-9-20(29(19)15-11-22-25-13-16-30-22)24(2)17-28-14-4-3-10-21(28)27-24/h3-4,6-7,10,12-14,16,19-20H,5,8-9,11,15,17H2,1-2H3/t19-,20+,24?/m0/s1
InChIKeyDPYBAJGLUQTADP-ZPVKFHTISA-N
MW403.53 g/mol
LogP4.07
Rot. Bonds5

About 2-[2-[(2R,6S)-2-(2-methyl-3H-imidazo[1,2-a]pyridin-2-yl)-6-(3-methyl-2-pyridinyl)piperidin-1-yl]ethyl]-1,3-oxazole

2-[2-[(2R,6S)-2-(2-methyl-3H-imidazo[1,2-a]pyridin-2-yl)-6-(3-methyl-2-pyridinyl)piperidin-1-yl]ethyl]-1,3-oxazole (PubChem CID 155373966) has the molecular formula C24H29N5O and a molecular weight of 403.53 g/mol. Its IUPAC name is 2-[2-[(2R,6S)-2-(2-methyl-3H-imidazo[1,2-a]pyridin-2-yl)-6-(3-methyl-2-pyridinyl)piperidin-1-yl]ethyl]-1,3-oxazole.

Molecular Properties

Compound Name2-[2-[(2R,6S)-2-(2-methyl-3H-imidazo[1,2-a]pyridin-2-yl)-6-(3-methyl-2-pyridinyl)piperidin-1-yl]ethyl]-1,3-oxazole
PubChem CID155373966
Molecular FormulaC24H29N5O
Molecular Weight403.53 g/mol
Exact Mass403.24
IUPAC Name2-[2-[(2R,6S)-2-(2-methyl-3H-imidazo[1,2-a]pyridin-2-yl)-6-(3-methyl-2-pyridinyl)piperidin-1-yl]ethyl]-1,3-oxazole
SMILESCc1cccnc1[C@@H]1CCC[C@H](C2(C)CN3C=CC=CC3=N2)N1CCc1ncco1
InChIInChI=1S/C24H29N5O/c1-18-7-6-12-26-23(18)19-8-5-9-20(29(19)15-11-22-25-13-16-30-22)24(2)17-28-14-4-3-10-21(28)27-24/h3-4,6-7,10,12-14,16,19-20H,5,8-9,11,15,17H2,1-2H3/t19-,20+,24?/m0/s1
InChIKeyDPYBAJGLUQTADP-ZPVKFHTISA-N
XLogP4.07
TPSA57.76 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds5
Heavy Atoms30
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500403.53
LogP ≤ 54.07
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Analyze 2-[2-[(2R,6S)-2-(2-methyl-3H-imidazo[1,2-a]pyridin-2-yl)-6-(3-methyl-2-pyridinyl)piperidin-1-yl]ethyl]-1,3-oxazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[2-[(2R,6S)-2-(2-methyl-3H-imidazo[1,2-a]pyridin-2-yl)-6-(3-methyl-2-pyridinyl)piperidin-1-yl]ethyl]-1,3-oxazole?
The IUPAC name of 2-[2-[(2R,6S)-2-(2-methyl-3H-imidazo[1,2-a]pyridin-2-yl)-6-(3-methyl-2-pyridinyl)piperidin-1-yl]ethyl]-1,3-oxazole (CID 155373966) is 2-[2-[(2R,6S)-2-(2-methyl-3H-imidazo[1,2-a]pyridin-2-yl)-6-(3-methyl-2-pyridinyl)piperidin-1-yl]ethyl]-1,3-oxazole.
What is the SMILES notation for 2-[2-[(2R,6S)-2-(2-methyl-3H-imidazo[1,2-a]pyridin-2-yl)-6-(3-methyl-2-pyridinyl)piperidin-1-yl]ethyl]-1,3-oxazole?
The canonical SMILES for 2-[2-[(2R,6S)-2-(2-methyl-3H-imidazo[1,2-a]pyridin-2-yl)-6-(3-methyl-2-pyridinyl)piperidin-1-yl]ethyl]-1,3-oxazole is Cc1cccnc1[C@@H]1CCC[C@H](C2(C)CN3C=CC=CC3=N2)N1CCc1ncco1.
What is the InChIKey of 2-[2-[(2R,6S)-2-(2-methyl-3H-imidazo[1,2-a]pyridin-2-yl)-6-(3-methyl-2-pyridinyl)piperidin-1-yl]ethyl]-1,3-oxazole?
The InChIKey is DPYBAJGLUQTADP-ZPVKFHTISA-N. The full InChI is InChI=1S/C24H29N5O/c1-18-7-6-12-26-23(18)19-8-5-9-20(29(19)15-11-22-25-13-16-30-22)24(2)17-28-14-4-3-10-21(28)27-24/h3-4,6-7,10,12-14,16,19-20H,5,8-9,11,15,17H2,1-2H3/t19-,20+,24?/m0/s1.
What are the key properties of 2-[2-[(2R,6S)-2-(2-methyl-3H-imidazo[1,2-a]pyridin-2-yl)-6-(3-methyl-2-pyridinyl)piperidin-1-yl]ethyl]-1,3-oxazole?
2-[2-[(2R,6S)-2-(2-methyl-3H-imidazo[1,2-a]pyridin-2-yl)-6-(3-methyl-2-pyridinyl)piperidin-1-yl]ethyl]-1,3-oxazole has a molecular weight of 403.53 g/mol, XLogP of 4.07, 5 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[2-[(2R,6S)-2-(2-methyl-3H-imidazo[1,2-a]pyridin-2-yl)-6-(3-methyl-2-pyridinyl)piperidin-1-yl]ethyl]-1,3-oxazole is sourced from PubChem (CID 155373966), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).